- 44% of Homeowners With a Mortgage Can't Sell: Zillow
- Tim Cook Should Tell Congress to Kiss His Ass
- Millennials Won't Be Debt Free Until They Die
- Biotech Stock Mailbag: Amarin, MannKind, Palatin
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
Article
In today's numbers, in order to feel what we felt as those experienced in a previous massive bull run, the S&P 500 would have to rally from the current 1500 level to over 2500, doing so by December.
10:30AM 02/28/13
Article
Skip Raschke explains what you need to know about gaps if you are going to trade options.
08:56AM 01/22/13
Article
The Totally Hedged Market/Capital Neutral Strategy
This plan was built on the following list of personal rules, listed by most important at the top.
03:04PM 12/05/12
Article
Skip Raschke: Stock Trading Halts, Part 3
In final part of the series, I review strategies to employ post-halt.
10:02AM 11/16/12
Article
Skip Raschke: Averaging In, Part Two
Prior to initiating any trade, you must make these critical decisions so you will be in complete control of your risk.
09:50AM 10/25/12
Article
This trade is purely a technical call on speculation.
09:27AM 10/22/12
Article
How I handle each and every trade setup is done by what I call averaging in.
09:24AM 10/18/12
Article
AA is starting to coil and I am bullish technically and fundamentally.
09:03AM 10/08/12
Article
Cardinal Health lines up well fundamentally and technically for a straight call buy.
11:36AM 06/11/12
Article
Jill Malandrino and Scott Redler, Chief Strategic Officer of T3Live review the fundamentals and technicals of OXY. Skip Raschke ties it all in with the options trade.
09:50AM 04/24/12